;PMID: 4063404
;source_file_1002.mrg
;Release 0.9 of PennBioIE
;Funded by NSF ITR EIA-0205448

;0)section:[e:0..36] = [t:0..36]
;1)sentence:[e:42..200] = [t:42..200]
;2)section:[e:204..224] = [t:204..224]
;3)section:[e:228..266] = [t:228..266]
;4)sentence:[e:270..480] = [t:270..480]
;5)sentence:[e:481..617] = [t:481..617]
;6)sentence:[e:618..877] = [t:618..877]
;7)sentence:[e:879..1246] = [t:879..1246]
;8)sentence:[e:1247..1522] = [t:1247..1522]
;9)sentence:[e:1523..1685] = [t:1523..1685]
;10)sentence:[e:1686..1817] = [t:1686..1817]
;11)sentence:[e:1818..2085] = [t:1818..2085]
;12)section:[e:2089..2133] = [t:2089..2133]

;section 0 Span:0..36
;Biokhimiia. 1985 Nov;50(11):1817-24.
(SEC
  (FRAG (NNP:[0..10] Biokhimiia) (IN:[10..11] .) (CD:[12..16] 1985)
        (CC:[17..24] Nov;50-LRB-) (CD:[24..26] 11) (-RRB-:[26..27] -RRB-)
        (CD:[27..32] :1817) (::[32..33] -) (CD:[33..35] 24) (.:[35..36] .)))

;sentence 1 Span:42..200
;[Induction of cytochrome P-450 forms in liver microsomes of rats in the early
; neonatal period after administration of phenobarbital and
;3-methylcholanthrene]
;[56..72]:cyp450:"cytochrome P-450"
;[161..174]:substance:"phenobarbital"
;[179..199]:substance:"3-methylcholanthrene"
(SENT
  (NP-HLN (-LRB-:[42..43] -LSB-)
    (NP (NN:[43..52] Induction))
    (PP (IN:[53..55] of)
      (NP
        (NML (NN:[56..66] cytochrome) (NN:[67..72] P-450))
        (NNS:[73..78] forms)))
    (PP-LOC (IN:[79..81] in)
      (NP
        (NP (NN:[82..87] liver) (NNS:[88..98] microsomes))
        (PP (IN:[99..101] of)
          (NP
            (NP (NNS:[102..106] rats))
            (PP (IN:[107..109] in)
              (NP (DT:[110..113] the) (JJ:[114..119] early)
                  (JJ:[121..129] neonatal) (NN:[130..136] period)))))))
    (PP-TMP (IN:[137..142] after)
      (NP
        (NP (NN:[143..157] administration))
        (PP (IN:[158..160] of)
          (NP (NN:[161..174] phenobarbital) (CC:[175..178] and)
              (NN:[179..199] 3-methylcholanthrene)))))
    (-RRB-:[199..200] -RSB-)))

;section 2 Span:204..224
;[Article in Russian]
(SEC
  (FRAG (NNP:[204..212] -LSB-Article) (IN:[213..215] in)
        (NNP:[216..223] Russian) (.:[223..224] -RSB-)))

;section 3 Span:228..266
;Guliaeva LF, Mishin VM, Liakhovich VV.
(SEC
  (FRAG (NNP:[228..236] Guliaeva) (NNP:[237..239] LF) (,:[239..240] ,)
        (NNP:[241..247] Mishin) (NNP:[248..250] VM) (,:[250..251] ,)
        (NNP:[252..262] Liakhovich) (NNP:[263..265] VV) (.:[265..266] .)))

;sentence 4 Span:270..480
;The activity of cytochrome P-450 dependent monooxygenase system from rat
;liver  microsomes after induction by phenobarbital and 3-methylcholantrene in
;early  neonatal period (3-16 days after birth) was studied.
;[286..326]:substance:"cytochrome P-450 dependent monooxygenase"
;[380..393]:substance:"phenobarbital"
;[398..417]:substance:"3-methylcholantrene"
;[445..449]:quantitative-value:"3-16"
;[450..454]:quantitative-units:"days"
(SENT
  (S
    (NP-SBJ-1
      (NP (DT:[270..273] The) (NN:[274..282] activity))
      (PP (IN:[283..285] of)
        (NP
          (NP
            
            (ADJP
              (NML (NN:[286..296] cytochrome) (NN:[297..302] P-450))
              (JJ:[303..312] dependent))
            (NN:[313..326] monooxygenase)
            (NN:[327..333] system))
          (PP (IN:[334..338] from)
            (NP (NN:[339..342] rat) (NN:[343..348] liver)
                (NNS:[350..360] microsomes)))
          (PP-TMP (IN:[361..366] after)
            (NP
              (NP (NN:[367..376] induction))
              (PP (IN:[377..379] by)
                (NP (NN:[380..393] phenobarbital) (CC:[394..397] and)
                    (NN:[398..417] 3-methylcholantrene)))
              (PP (IN:[418..420] in)
                (NP (JJ:[421..426] early) (JJ:[428..436] neonatal)
                    (NN:[437..443] period)
                  (PRN (-LRB-:[444..445] -LRB-)
                    (NP-TMP
                      (NP
                        (QP (CD:[445..446] 3) (HYPH:[446..447] -)
                            (CD:[447..449] 16))
                        (NNS:[450..454] days))
                      (PP (IN:[455..460] after)
                        (NP (NN:[461..466] birth))))
                    (-RRB-:[466..467] -RRB-)))))))))
    (VP (VBD:[468..471] was)
      (VP (VBN:[472..479] studied)
        (NP-1 (-NONE-:[479..479] *))))
    (.:[479..480] .)))

;sentence 5 Span:481..617
;It was found that the total  amount of cytochrome P-450 increases after
;injection of these inducers in  neonatal rats of all age groups.
;[520..536]:cyp450:"cytochrome P-450"
;[572..580]:substance:"inducers"
(SENT
  (S
    (NP-SBJ-2
      (NP (PRP:[481..483] It))
      (SBAR-1 (-NONE-:[483..483] *EXP*)))
    (VP (VBD:[484..487] was)
      (VP (VBN:[488..493] found)
        (NP-2 (-NONE-:[493..493] *))
        (SBAR-1 (IN:[494..498] that)
          (S
            (NP-SBJ
              (NP-SBJ (DT:[499..502] the) (NN:[503..508] total)
                      (NN:[510..516] amount))
              (PP (IN:[517..519] of)
                (NP (NN:[520..530] cytochrome) (NN:[531..536] P-450))))
            (VP (VBZ:[537..546] increases)
              (PP-TMP (IN:[547..552] after)
                (NP
                  (NP (NN:[553..562] injection))
                  (PP (IN:[563..565] of)
                    (NP (DT:[566..571] these) (NNS:[572..580] inducers)))))
              (PP-LOC (IN:[581..583] in)
                (NP
                  (NP (JJ:[585..593] neonatal) (NNS:[594..598] rats))
                  (PP (IN:[599..601] of)
                    (NP (DT:[602..605] all) (NN:[606..609] age)
                        (NNS:[610..616] groups))))))))))
    (.:[616..617] .)))

;sentence 6 Span:618..877
;In parallel, in the case of 3-methylcholantrene  induction the benz(a)pyrene
;hydroxylase and 7-ethoxyresorufin deethylase  activities increase;
;phenobarbital induction causes a rise in the  benzphetamine-N-demethylase and
;benz(a)pyrene hydroxylase activities.
;[646..665]:substance:"3-methylcholantrene"
;[681..706]:cyp450:"benz(a)pyrene hydroxylase"
;[711..739]:cyp450:"7-ethoxyresorufin deethylase"
;[762..775]:substance:"phenobarbital"
;[808..835]:cyp450:"benzphetamine-N-demethylase"
;[840..865]:cyp450:"benz(a)pyrene hydroxylase"
(SENT
  (S
    (S
      (PP (IN:[618..620] In)
        (NP (NN:[621..629] parallel)))
      (,:[629..630] ,)
      (PP (IN:[631..633] in)
        (NP
          (NP (DT:[634..637] the) (NN:[638..642] case))
          (PP (IN:[643..645] of)
            (NP (NN:[646..665] 3-methylcholantrene) (NN:[667..676] induction)))))
      (NP-SBJ (DT:[677..680] the)
        (NML
          (NML
             (NN:[681..694] benz-LRB-a-RRB-pyrene) (NN:[695..706] hydroxylase)
            (NML-1 (-NONE-:[706..706] *P*)))
          (CC:[707..710] and)
          (NML
             (NN:[711..728] 7-ethoxyresorufin) (NN:[729..739] deethylase)
            (NML-1 (NNS:[741..751] activities)))))
      (VP (VBP:[752..760] increase)))
    (::[760..761] ;)
    (S
      (NP-SBJ (NN:[762..775] phenobarbital) (NN:[776..785] induction))
      (VP (VBZ:[786..792] causes)
        (NP
          (NP (DT:[793..794] a) (NN:[795..799] rise))
          (PP (IN:[800..802] in)
            (NP (DT:[803..806] the)
              (NML
                (NML (NN:[808..835] benzphetamine-N-demethylase)
                  (NML-2 (-NONE-:[835..835] *P*)))
                (CC:[836..839] and)
                (NML
                   (NN:[840..853] benz-LRB-a-RRB-pyrene)
                   (NN:[854..865] hydroxylase)
                  (NML-2 (NNS:[866..876] activities)))))))))
    (.:[876..877] .)))

;sentence 7 Span:879..1246
;Immunochemical analysis involving the use of antibodies specifically directed
; against cytochrome P-450 of adult rats revealed that the level of cytochrome
; P-450 in the case of 3-methylcholantrene induction increases from 5 to 50%, 
;whereas that of cytochrome P-450 upon phenobarbital induction increases from
;5  to 40% in liver microsomes of 3- and 16-day-old rats.
;[924..934]:substance:"antibodies"
;[966..982]:cyp450:"cytochrome P-450"
;[1024..1041]:cyp450:"cytochrome  P-450"
;[1057..1076]:substance:"3-methylcholantrene"
;[1102..1110]:quantitative-value:"5 to 50%"
;[1129..1145]:cyp450:"cytochrome P-450"
;[1151..1164]:substance:"phenobarbital"
;[1190..1199]:quantitative-value:"5  to 40%"
;[1223..1224]:quantitative-value:"3"
;[1230..1232]:quantitative-value:"16"
;[1233..1236]:quantitative-units:"day"
(SENT
  (S
    (NP-SBJ
      (NP (JJ:[879..893] Immunochemical) (NN:[894..902] analysis))
      (VP (VBG:[903..912] involving)
        (NP
          (NP (DT:[913..916] the) (NN:[917..920] use))
          (PP (IN:[921..923] of)
            (NP
              (NP (NNS:[924..934] antibodies))
              (VP
                (ADVP (RB:[935..947] specifically))
                (VBN:[948..956] directed)
                (NP (-NONE-:[956..956] *))
                (PP (IN:[958..965] against)
                  (NP
                    (NP (NN:[966..976] cytochrome) (NN:[977..982] P-450))
                    (PP (IN:[983..985] of)
                      (NP (JJ:[986..991] adult) (NNS:[992..996] rats)))))))))))
    (VP (VBD:[997..1005] revealed)
      (SBAR (IN:[1006..1010] that)
        (S
          (NP-SBJ
            (NP (DT:[1011..1014] the) (NN:[1015..1020] level))
            (PP (IN:[1021..1023] of)
              (NP (NN:[1024..1034] cytochrome) (NN:[1036..1041] P-450)))
            (PP (IN:[1042..1044] in)
              (NP
                (NP (DT:[1045..1048] the) (NN:[1049..1053] case))
                (PP (IN:[1054..1056] of)
                  (NP (NN:[1057..1076] 3-methylcholantrene)
                      (NN:[1077..1086] induction))))))
          (VP (VBZ:[1087..1096] increases)
            (NP-EXT
              (QP (IN:[1097..1101] from) (CD:[1102..1103] 5)
                  (TO:[1104..1106] to) (CD:[1107..1109] 50))
              (NN:[1109..1110] %))
            (,:[1110..1111] ,)
            (SBAR-ADV (IN:[1113..1120] whereas)
              (S
                (NP-SBJ
                  (NP (DT:[1121..1125] that))
                  (PP (IN:[1126..1128] of)
                    (NP
                      (NP (NN:[1129..1139] cytochrome) (NN:[1140..1145] P-450))
                      (PP-TMP (IN:[1146..1150] upon)
                        (NP (NN:[1151..1164] phenobarbital)
                            (NN:[1165..1174] induction))))))
                (VP (VBZ:[1175..1184] increases)
                  (NP-EXT
                    (QP (IN:[1185..1189] from) (CD:[1190..1191] 5)
                        (TO:[1193..1195] to) (CD:[1196..1198] 40))
                    (NN:[1198..1199] %))
                  (PP-LOC (IN:[1200..1202] in)
                    (NP
                      (NP (NN:[1203..1208] liver) (NNS:[1209..1219] microsomes))
                      (PP (IN:[1220..1222] of)
                        (NP
                          (NP
                            (ADJP
                              (NML (CD:[1223..1224] 3) (HYPH:[1224..1225] -)
                                (NML-3 (-NONE-:[1225..1225] *P*)))
                              (ADJP-1 (-NONE-:[1225..1225] *P*)))
                            (NML-2 (-NONE-:[1225..1225] *P*)))
                          (CC:[1226..1229] and)
                          (NP
                            (ADJP
                              (NML (CD:[1230..1232] 16) (HYPH:[1232..1233] -)
                                (NML-3 (NN:[1233..1236] day)))
                              (ADJP-1 (HYPH:[1236..1237] -)
                                      (JJ:[1237..1240] old)))
                            (NML-2 (NNS:[1241..1245] rats))))))))))))))
    (.:[1245..1246] .)))

;sentence 8 Span:1247..1522
;The mode of inhibition of  various substrates metabolism by antibodies in
;neonatal rat microsomes suggests  that the 3-methylcholantrene-induced
;cytochrome P-448, like in adult rats,  participates in the hydroxylation of
;benz(a)pyrene and O-deethylation of  7-etoxyresorufin.
;[1282..1292]:substance:"substrates"
;[1307..1317]:substance:"antibodies"
;[1364..1383]:substance:"3-methylcholantrene"
;[1392..1408]:cyp450:"cytochrome P-448"
;[1468..1481]:substance:"benz(a)pyrene"
;[1505..1521]:substance:"7-etoxyresorufin"
(SENT
  (S
    (NP-SBJ
      (NP (DT:[1247..1250] The) (NN:[1251..1255] mode))
      (PP (IN:[1256..1258] of)
        (NP
          (NP (NN:[1259..1269] inhibition))
          (PP (IN:[1270..1272] of)
            (NP (JJ:[1274..1281] various) (NNS:[1282..1292] substrates)
                (NN:[1293..1303] metabolism)))
          (PP (IN:[1304..1306] by)
            (NP (NNS:[1307..1317] antibodies)))
          (PP-LOC (IN:[1318..1320] in)
            (NP (JJ:[1321..1329] neonatal) (NN:[1330..1333] rat)
                (NNS:[1334..1344] microsomes))))))
    (VP (VBZ:[1345..1353] suggests)
      (SBAR (IN:[1355..1359] that)
        (S
          (NP-SBJ (DT:[1360..1363] the)
            (ADJP (NN:[1364..1383] 3-methylcholantrene) (HYPH:[1383..1384] -)
                  (VBN:[1384..1391] induced))
             (NN:[1392..1402] cytochrome) (NN:[1403..1408] P-448))
          (,:[1408..1409] ,)
          (S-ADV
            (NP-SBJ (-NONE-:[1409..1409] *))
            (ADJP-PRD (IN:[1410..1414] like)
              (PP-LOC (IN:[1415..1417] in)
                (NP (JJ:[1418..1423] adult) (NNS:[1424..1428] rats)))))
          (,:[1428..1429] ,)
          (VP (VBZ:[1431..1443] participates)
            (PP (IN:[1444..1446] in)
              (NP (DT:[1447..1450] the)
                (NML
                  (NML
                    (NML (NN:[1451..1464] hydroxylation))
                    (PP (IN:[1465..1467] of)
                      (NP (NN:[1468..1481] benz-LRB-a-RRB-pyrene))))
                  (CC:[1482..1485] and)
                  (NML
                    (NML (NN:[1486..1500] O-deethylation))
                    (PP (IN:[1501..1503] of)
                      (NP (NN:[1505..1521] 7-etoxyresorufin)))))))))))
    (.:[1521..1522] .)))

;sentence 9 Span:1523..1685
;The participation of phenobarbital-induced cytochrome P-450 in  the
;metabolism of benzphetamine and aldrin in neonatal rats is much lower than 
;in the adult ones.
;[1544..1557]:substance:"phenobarbital"
;[1566..1582]:cyp450:"cytochrome P-450"
;[1605..1618]:substance:"benzphetamine"
;[1623..1629]:substance:"aldrin"
(SENT
  (S
    (NP-SBJ
      (NP (DT:[1523..1526] The) (NN:[1527..1540] participation))
      (PP (IN:[1541..1543] of)
        (NP
          (ADJP (NN:[1544..1557] phenobarbital) (HYPH:[1557..1558] -)
                (VBN:[1558..1565] induced))
           (NN:[1566..1576] cytochrome) (NN:[1577..1582] P-450)))
      (PP (IN:[1583..1585] in)
        (NP
          (NP (DT:[1587..1590] the) (NN:[1591..1601] metabolism))
          (PP (IN:[1602..1604] of)
            (NP (NN:[1605..1618] benzphetamine) (CC:[1619..1622] and)
                (NN:[1623..1629] aldrin)))
          (PP-LOC (IN:[1630..1632] in)
            (NP (JJ:[1633..1641] neonatal) (NNS:[1642..1646] rats))))))
    (VP (VBZ:[1647..1649] is)
      (ADJP-PRD
        (ADJP (RB:[1650..1654] much) (JJR:[1655..1660] lower))
        (PP (IN:[1661..1665] than)
          (PP-LOC (IN:[1667..1669] in)
            (NP (DT:[1670..1673] the) (JJ:[1674..1679] adult)
                (NNS:[1680..1684] ones))))))
    (.:[1684..1685] .)))

;sentence 10 Span:1686..1817
;The metabolism of benz(a)pyrene in phenobarbital-induced  neonatal rat
;microsomes in all age groups is not inhibited by antibodies.
;[1704..1717]:substance:"benz(a)pyrene"
;[1721..1734]:substance:"phenobarbital"
;[1806..1816]:substance:"antibodies"
(SENT
  (S
    (NP-SBJ-1
      (NP (DT:[1686..1689] The) (NN:[1690..1700] metabolism))
      (PP (IN:[1701..1703] of)
        (NP (NN:[1704..1717] benz-LRB-a-RRB-pyrene)))
      (PP-LOC (IN:[1718..1720] in)
        (NP
          (NP
            (ADJP (NN:[1721..1734] phenobarbital) (HYPH:[1734..1735] -)
                  (VBN:[1735..1742] induced))
            (JJ:[1744..1752] neonatal) (NN:[1753..1756] rat)
             (NNS:[1757..1767] microsomes))
          (PP (IN:[1768..1770] in)
            (NP (DT:[1771..1774] all) (NN:[1775..1778] age)
                (NNS:[1779..1785] groups))))))
    (VP (VBP:[1786..1788] is) (RB:[1789..1792] not)
      (VP (VBN:[1793..1802] inhibited)
        (NP-1 (-NONE-:[1802..1802] *))
        (PP (IN:[1803..1805] by)
          (NP-LGS (NNS:[1806..1816] antibodies)))))
    (.:[1816..1817] .)))

;sentence 11 Span:1818..2085
;The  age-dependent differences in inhibition of metabolism and the increase
;in the  benz(a)pyrene hydroxylase activity in phenobarbital-induced rats
;suggest that  the spectrum of inducible forms of cytochrome P-450 in neonatal
;rats differ from  that in adult animals.
;[1902..1927]:cyp450:"benz(a)pyrene hydroxylase"
;[1940..1953]:substance:"phenobarbital"
;[2016..2032]:cyp450:"cytochrome P-450"
(SENT
  (S
    (NP-SBJ
      (NP
        (NP (DT:[1818..1821] The)
          (ADJP (NN:[1823..1826] age) (HYPH:[1826..1827] -)
                (JJ:[1827..1836] dependent))
          (NNS:[1837..1848] differences))
        (PP (IN:[1849..1851] in)
          (NP
            (NP (NN:[1852..1862] inhibition))
            (PP (IN:[1863..1865] of)
              (NP (NN:[1866..1876] metabolism))))))
      (CC:[1877..1880] and)
      (NP
        (NP (DT:[1881..1884] the) (NN:[1885..1893] increase))
        (PP (IN:[1894..1896] in)
          (NP (DT:[1897..1900] the)
            (NML (NN:[1902..1915] benz-LRB-a-RRB-pyrene)
                 (NN:[1916..1927] hydroxylase))
            (NN:[1928..1936] activity)))
        (PP-LOC (IN:[1937..1939] in)
          (NP
            (ADJP (NN:[1940..1953] phenobarbital) (HYPH:[1953..1954] -)
                  (VBN:[1954..1961] induced))
            (NNS:[1962..1966] rats)))))
    (VP (VBP:[1967..1974] suggest)
      (SBAR (IN:[1975..1979] that)
        (S
          (NP-SBJ
            (NP (DT:[1981..1984] the) (NN:[1985..1993] spectrum))
            (PP (IN:[1994..1996] of)
              (NP
                (NP (JJ:[1997..2006] inducible) (NNS:[2007..2012] forms))
                (PP (IN:[2013..2015] of)
                  (NP (NN:[2016..2026] cytochrome) (NN:[2027..2032] P-450)))))
            (PP-LOC (IN:[2033..2035] in)
              (NP (JJ:[2036..2044] neonatal) (NNS:[2045..2049] rats))))
          (VP (VBP:[2050..2056] differ)
            (PP (IN:[2057..2061] from)
              (NP
                (NP (DT:[2063..2067] that))
                (PP-LOC (IN:[2068..2070] in)
                  (NP (JJ:[2071..2076] adult) (NNS:[2077..2084] animals)))))))))
    (.:[2084..2085] .)))

;section 12 Span:2089..2133
;PMID: 4063404 [PubMed - indexed for MEDLINE]
(SEC
  (FRAG (NNP:[2089..2093] PMID) (::[2093..2094] :) (CD:[2095..2102] 4063404)
        (NN:[2103..2104] -LSB-) (NNP:[2104..2110] PubMed) (::[2111..2112] -)
        (NN:[2113..2120] indexed) (IN:[2121..2124] for)
        (NNP:[2125..2133] MEDLINE-RSB-)))
